As we look for signs of a tradeable low in Equities, we're not only looking at breadth and the stock market's leaders, we're also looking to the Commodity market for a signal of what's to come.

Let's get into why Copper needs to be on your radar.

In our last post, we looked at the implications of the Nifty 500's breadth and momentum divergences.

In this post, we're outlining the three charts we're watching this week to help determine risk appetite for stocks.

Last week we started to see a few momentum and breadth divergences form in Indian stocks, however, they've not yet been confirmed by price.

In this post, we're going to outline what price level in the Nifty 500 would confirm them, what confirmation would mean for our intermediate-term outlook, and how we're managing risk in both scenarios.

Warning signals were piling up throughout 2020, but weak breadth has been an underlying issue for Indian stocks since they made new highs in August 2016.

While we wait for breadth and momentum divergences to form and suggest getting aggressive on the long side, we're going to look back at how the average Nifty 500 stock has performed over the last 3.5 years and why this data is relevant to today's market.

While we wait for the breadth and momentum divergences to develop in the equity markets, we're taking advantage of other markets that offer uncorrelated trade opportunities.

Today, we're looking at Jeera and Crude Palm Oil on the long side.

In this type of environment, our focus has been on capital preservation as opposed to capital appreciation.

We've gotten a lot of questions about Metals during this time, so this post will review why we've been out and what would get us involved again.

We got a lower low in equities, followed by continued weakness rather than stabilization. Heavy cash positions and a defensive posture remains best in this historically volatile environment.

Given how quickly things are moving, there are three charts on our screen that will help identify when a shift in the market is occuring.

Last week we outlined our thesis for a lower low in Indian stocks, as well as what it would take for us to get more aggressive on the long side.

After another sharp move lower with dramatic blowups in  Yes Bank and Crude Oil, let's revisit that thesis and discuss why patience remains the best course of action given current conditions.

Yes Bank is in the news again and following an 83% intraday move to the downside, market participants are wondering what's next?

In this post, we'll outline why this week's move is business as usual for the stock, what we'd do with it now, and why the best trade in Yes Bank may be to avoid it altogether.

The current market environment remains choppy, so we want to revisit a sector that's showing relative strength, Pharma.

In November we pointed to the improving prospects of the Nifty Pharma Index and its components, following up with additional trades in January.

Today, we want to revisit the sector to see what's changed and what stocks we want to be buying and selling.

First, let's start with the Nifty Pharma vs Nifty 500 ratio chart that continues to turn higher after meeting our downside objective late last year. This continues to suggest further outperformance from the Nifty Pharma sector relative to the broader market.

Click on chart to enlarge view. 

Two weeks ago we wrote about the underlying weakness of the Nifty IT Sector, but today we're highlighting a stock in the space that continues to show relative strength in the face of a weak market.